This collection contains detailed discussion of potentially difficult aspects of recent recommendations for the classification of chronic interstitial pneumonias, challenging areas of the upcoming WHO ...

A biology-guided artificial intelligence model applied to routine pathology slides accurately predicted outcomes and response ...

Using a new method called ‘high parameter imaging mass cytometry’ scientists visualize detailed cellular landscapes of the lung in infectious lung diseases at never-before-seen, single-cell resolution ...

A deep learning platform may help predict how people with advanced lung cancer will respond to immunotherapy, according to study results.Patients determined by a biology-guided AI model to be at high ...

Researchers have used advanced technology and analytics to map, at single-cell resolution, the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases. A team ...

Results of a new study conclude that a pathology tool powered by artificial intelligence can predict whether a patient with extensive-stage small cell lung cancer will respond to platinum-based ...

The UAB Lung Biology Program provides a cutting-edge and interdisciplinary hub for scientists, clinicians, and the next generation of researchers to accelerate understanding of lung biology through ...

Association of early tumor growth rate and survival outcomes in first-line metastatic non–small cell lung cancer (mNSCLC). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...

The customizable platform used AAVs to deliver genetic cargo that induced the production of three anti-inflammatory cytokines ...

Dr. Emerson's service work is predominantly in general surgical pathology with a subspecialty interest in pulmonary pathology. Her research efforts are currently in the area of lung cancer genomics.

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.